|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2010-8-5
|
|
pubmed:abstractText |
Current guidelines suggest that primary prophylaxis for Pneumocystis jiroveci pneumonia (PcP) can be safely stopped in human immunodeficiency virus (HIV)-infected patients who are receiving combined antiretroviral therapy (cART) and who have a CD4 cell count >200 cells/microL. There are few data regarding the incidence of PcP or safety of stopping prophylaxis in virologically suppressed patients with CD4 cell counts of 101-200 cells/microL.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1537-6591
|
|
pubmed:author |
pubmed-author:BucherHeiner CHC,
pubmed-author:CheneGenevieveG,
pubmed-author:De WitStephaneS,
pubmed-author:DoerholtKatjaK,
pubmed-author:FurrerHansjakobH,
pubmed-author:GhosnJadeJ,
pubmed-author:GirardiEnricoE,
pubmed-author:KirkOleO,
pubmed-author:LundgrenJens DJD,
pubmed-author:MiroJose MJM,
pubmed-author:MocroftAmandaA,
pubmed-author:MorlatPhilippeP,
pubmed-author:MussiniCristinaC,
pubmed-author:Opportunistic Infections Project Team of the Collaboration of...,
pubmed-author:ReissPeterP,
pubmed-author:StephanChristophC
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
51
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
611-9
|
|
pubmed:dateRevised |
2010-11-22
|
|
pubmed:meshHeading |
pubmed-meshheading:20645862-AIDS-Related Opportunistic Infections,
pubmed-meshheading:20645862-Adult,
pubmed-meshheading:20645862-Anti-HIV Agents,
pubmed-meshheading:20645862-Antifungal Agents,
pubmed-meshheading:20645862-CD4 Lymphocyte Count,
pubmed-meshheading:20645862-Europe,
pubmed-meshheading:20645862-Female,
pubmed-meshheading:20645862-HIV Infections,
pubmed-meshheading:20645862-Humans,
pubmed-meshheading:20645862-Incidence,
pubmed-meshheading:20645862-Male,
pubmed-meshheading:20645862-Middle Aged,
pubmed-meshheading:20645862-Pneumocystis jirovecii,
pubmed-meshheading:20645862-Pneumonia, Pneumocystis,
pubmed-meshheading:20645862-Risk Factors
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/microL?
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
